Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Syntho Pharmaceuticals, Inc.
FDA Inspection
•Syntho Pharmaceuticals, Inc.•September 3, 2019

Syntho Pharmaceuticals, Inc. – FDA Inspection, Sep 3, 2019

Record Details

This FDA Inspection record concerns Syntho Pharmaceuticals, Inc., with an inspection on September 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Syntho Pharmaceuticals, Inc.
Inspection Date
September 3, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jose O. Hernandez (Company Rep)
View Company Profile

ID · 5e5a46a6-4a9d-4121-a178-563561e5834b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1101047
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

13
  1. 21 CFR 211.137(a)Expiration date lacking
  2. 21 CFR 211.160(a)Following/documenting laboratory controls
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.160(b)(4)Establishment of calibration procedures
  5. 21 CFR 211.198(a)Procedures to be written and followed
  6. 21 CFR 211.170(b)Annual visual exams of drug products
  7. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  8. 21 CFR 211.160(b)(4)Test devices not meeting specifications
  9. 21 CFR 211.165(e)Test methods
  10. 21 CFR 211.180(e)(1)Review of representative number of batches

Showing 10 of 13 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Syntho Pharmaceuticals, Inc.

9
DateClassificationOfficeProject area
March 1, 2024Not classifiedNew York District OfficeDrug Quality Assurance
March 9, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 26, 2016OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 23, 2013OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 21, 2012OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 9 other inspections on the company page
Other documents for Syntho Pharmaceuticals, Inc.
  • FDA Inspection 1231554 - 2024-03-01
  • FDA Inspection 1003899 - 2017-03-09
  • FDA Inspection 984108 - 2016-08-26
  • FDA Inspection 844933 - 2013-08-23
  • FDA Inspection 768857 - 2012-02-21

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Syntho Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.